Ipraflo DPI Capsule

Short Description

Ipraflo DPI Capsule is used for the treatment of chronic obstructive pulmonary disorder (COPD) by relaxing the muscles of the air passages and making it easier to breathe.

Dosage Form

Powder for Inhalation

Introduction

Ipraflo DPI Capsule is a combination of two medicines that makes breathing easier for patients with chronic obstructive pulmonary disease (COPD). It helps in relaxing the muscles of the air passages and making it easier to breathe. It relieves coughing, wheezing and feeling short of breath.

Use it as advised by your doctor or check the label for directions before use.

Ipraflo DPI Capsule is a combination of two medicines: Levosalbutamol and Ipratropium. Levosalbutamol is a bronchodilator while Ipratropium is an anticholinergic. They work by relaxing the muscles in the airways and widen the airways. Together they make breathing easier.

Ipraflo DPI Capsule is a combination of two medicines that makes breathing easier for patients with chronic obstructive pulmonary disease (COPD). This medicine is for inhalation only. The tablet should not be swallowed. It should be taken at the same time each day. It does not work right away and should not be used to relieve sudden breathing problems. Use your rescue inhaler to control sudden difficulty in breathing. Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help. Gargle with warm water after each inhalation to avoid any fungal infections in your mouth and throat. Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using. Your doctor may regularly monitor your blood potassium level as low oxygen level in the blood (hypoxia) and medicines such as Ipraflo DPI Capsule can lower blood potassium level. Only miniscule amounts of Ipraflo DPI Capsule may get absorbed into the bloodstream after inhalation. Hence serious side effects are unlikely.